PBM

Psyence Biomedical Ltd. Common Shares (PBM)

Stock · NASDAQ · Health Care

$4.21as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$2.95
Industry
Biotechnology: Pharmaceutical Preparations

Fundamentals

Market cap
$12.02M
P/E (trailing)
P/E (forward)
EPS (trailing)
Dividend yield
Beta
Avg. volume

Psyence Biomedical Ltd. Common Shares Competitors

Chosen by industry and closest market cap.

  • PBM
    Psyence Biomedical Ltd. Common Shares
    $4.21
    ▼ 3.44%
    Market cap $12.02MP/E
  • PHIO
    Phio Pharmaceuticals Corp. Common Stock
    $1.13
    ▲ 0.45%
    Market cap $11.97MP/E
    $0.8127$4.19
  • AKTX
    Akari Therapeutics plc ADS
    $11.03
    ▲ 22.42%
    Market cap $12.88MP/E Infinity
    $3.02$49.6
  • COCP
    Cocrystal Pharma Inc. Common Stock
    $1.11
    ▼ 2.63%
    Market cap $12.96MP/E
    $0.76$2.67
  • AEON
    AEON Biopharma Inc. Class A Common Stock
    $0.3095
    ▲ 5.27%
    Market cap $14.41MP/E
    $0.1772$1.45
  • GDTC
    CytoMed Therapeutics Limited Ordinary Shares
    $0.92
    ▼ 4.17%
    Market cap $9.50MP/E
    $0.6801$3.68
  • PTN
    Palatin Technologies Inc. Common Stock
    $10.48
    ▼ 0.10%
    Market cap $14.64MP/E 85.09
    $5.61$31

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Institutional Ownership

March 31, 2026

Total shares held
151.3K
Total value held
$575.0K
Institutional holders
2
Top holders this quarter
  • Unknown151.3K
  • Unknown89

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.